Event Abstract

Effects of heat treatment on magnetic susceptibility and hardness of Au-Nb alloys for MRI Artifact-free Biomedical Applications

  • 1 Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Biomaterials and bioengineering, Japan
  • 2 Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Oral and Maxillofacial Radiology, Japan

Introduction: Metal devices in human body cause metals artifact in magnetic resonance imaging (MRI). The main cause of metals artifact is a susceptibility artifact induced by volume magnetic susceptibility (χv) mismatch between the metal and human tissue. The authors have developed Au-6Nb alloy with χv value similar to that of human tissue [approximately -9 × 10-6, (-9 ppm)]. However, Vickers hardness (HV) of the alloy (approximately 120HV) was insufficient for various biomedical applications. Increasing of Nb content was effective to increase HV of Au-Nb alloys, however, χv of the alloys increased simultaneously, and χv mismatch enhance. In this study, the χv and HV of Au-xNb alloys (x ≥ 6) were investigated, and the effects of heat treatment on them were clarified.

Experimental Methods: Au-xNb (x = 6, 8, 12, 15 and 19.1) alloy ingots were fabricated by argon-arc-melting. The ingots of lower Nb content (Nb = 6 and 8) were rolled at room temperature, and the ingots of higher Nb content (Nb = 12 and 15) were rolled at 573 K in air to a thickness of approximately 1-1.5 mm. The total rolling reduction was 50-70%. The rolled alloy plates were homogenized at 1273 K for 20 h. The plates after homogenization were then cut into pieces for evaluation. Au-19.1Nb alloy ingot was homogenized at 1273 K for 2 w, and then cut into pieces without rolling. Aging treatments were performed at 1073 K. The χv values were measured using a magnetic susceptibility balance; the HV was measured under a load of 100 g for 30 s; and the phase constitution was analysed using X-ray diffractometry (XRD).

Results and Discussion: In XRD profile of Au-19.1Nb alloy, only peaks of Au2Nb were observed. Thus, χv value of Au-19.1Nb alloy (-23 ppm) was assumed to be that of Au2Nb. χv value of Au-xNb alloys (x ≤ 12) increased linearly with increasing Nb content, however, χv value of Au-15Nb alloy (1 ppm) indicated reduction from Au-12Nb alloy (8 ppm). XRD profiles of Au-15Nb alloy showed the precipitation of Au2Nb. These results suggested that χv value of Au-Nb alloys of higher Nb content can be controlled by controlling amount of Au2Nb precipitation using aging treatment. 1073 K aging treatments for Au-12Nb alloy and Au-15Nb alloy certainly precipitated Au2Nb in the alloys and reduced χv values close to -9 ppm, which demonstrated that χv values of Au-Nb alloy with higher Nb content could be adjusted to -9 ppm. The maximum HV of Au-12Nb alloy and Au-15Nb alloy indicating χv value close to -9 ppm after aging treatment was approximately 230HV. This is nearly twice as much as that of Au-6Nb alloy also indicating χv value close to -9 ppm.

Conclusion: Aging treatment at 1073 K can reduce χv value of Au-Nb alloys with higher Nb content, and helps achieve a MRI artifact-free Au-Nb alloy with higher hardness.

A part of this work was financially supported by JSPS KAKENHI, Japan Science and Technology Agency, Tanaka Kikinzoku Research Fund and Terumo Foundation for Life Sciences and Arts.; JSPS KAKENHI; Japan Science and Technology Agency; Tanaka Kikinzoku Research Fund; Terumo Foundation for Life Sciences and Arts

Keywords: MRI, biomedical application, mechanical property

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Metallic biomaterials and alloys

Citation: Inui S, Hamada K, Uyama E and Honda E (2016). Effects of heat treatment on magnetic susceptibility and hardness of Au-Nb alloys for MRI Artifact-free Biomedical Applications. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01934

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.